Can You Take Keppra Plus Vimpat and Lexapro Together?
Yes, you can safely take Keppra (levetiracetam) together with Vimpat (lacosamide) and Lexapro (escitalopram) - this combination is commonly used in clinical practice without significant safety concerns.
Drug Interaction Profile
Keppra + Vimpat Combination
The combination of levetiracetam and lacosamide is well-established and safe:
No pharmacokinetic interactions: FDA labeling for Vimpat explicitly states that steady-state plasma concentrations of levetiracetam were not affected by concomitant intake of lacosamide at any dose 1
Synergistic efficacy: Preclinical studies demonstrate that lacosamide combined with levetiracetam produces synergistic anticonvulsant effects without exacerbation of adverse motor effects 2
Clinical safety data: Multiple studies confirm this combination is safe and well-tolerated. A 2023 study showed similar adherence rates (PDC 0.95 for lacosamide vs 0.94 for levetiracetam) with good 1-year persistence 3
No enhanced toxicity: Research specifically demonstrates that lacosamide and levetiracetam combination does not cause apoptosis in developing brains and shows no significant adverse events when administered together 4, 5
Adding Lexapro (Escitalopram)
Lexapro can be safely added to this antiepileptic regimen:
Minimal CYP450 interactions: Escitalopram has the least effect on CYP450 isoenzymes compared with other SSRIs and therefore has a lower propensity for drug interactions 6
No metabolic interference: Neither levetiracetam nor lacosamide significantly interact with CYP450 enzymes that metabolize escitalopram. Lacosamide does not induce or inhibit CYP1A2, 2B6, 2C9, 2C19, or 3A4 1
Seizure threshold consideration: While SSRIs can theoretically lower seizure threshold, escitalopram is generally well-tolerated in patients with epilepsy when seizures are adequately controlled with antiepileptic medications
Important Monitoring Considerations
Watch for These Specific Issues:
Psychiatric side effects (most important concern):
- Levetiracetam commonly causes psychiatric symptoms (irritability, mood changes, depression)
- A 2021 study found psychiatric disorders occurred in only 6.8% of patients on levetiracetam + lacosamide combination 7
- Monitor closely in the first month after starting or increasing doses, as psychiatric symptoms typically emerge within this timeframe 7
Cardiac monitoring (for lacosamide):
- Lacosamide can cause PR interval prolongation
- If adding escitalopram (which can prolong QT interval at doses >40 mg/day), obtain baseline and follow-up ECGs 6, 8
Potential drug level changes:
- One case report suggests lacosamide may lower levetiracetam levels, though this is not consistently observed 9
- Monitor seizure control; if breakthrough seizures occur, check drug levels
Common Pitfalls to Avoid
Don't assume psychiatric symptoms are "just depression": With levetiracetam on board, new psychiatric symptoms may be medication-related rather than requiring SSRI dose escalation
Don't overlook serotonin syndrome risk: While low with escitalopram alone, monitor for mental status changes, neuromuscular hyperactivity, and autonomic instability, especially in the first 24-48 hours after dose changes 6
Don't abruptly discontinue lacosamide: Withdrawal seizures can occur with abrupt discontinuation 8
Clinical Bottom Line
This three-drug combination is pharmacologically compatible and commonly used. The primary concern is monitoring for psychiatric side effects from levetiracetam (which may be misattributed to depression) and ensuring adequate seizure control. The combination of lacosamide with levetiracetam is actually preferable to some other antiepileptic combinations due to lower psychiatric adverse event rates 7.